...
首页> 外文期刊>Neuropsychopharmacology reports. >The dopamine D2 agonist quinpirole impairs frontal mismatch responses to sound frequency deviations in freely moving rats
【24h】

The dopamine D2 agonist quinpirole impairs frontal mismatch responses to sound frequency deviations in freely moving rats

机译:多巴胺D2激动剂Quinpirole在自由移动的大鼠中损害了对声频偏差的正面不匹配响应

获取原文
           

摘要

Aim A reduced mismatch negativity (MMN) response is a promising electrophysiological endophenotype of schizophrenia that reflects neurocognitive impairment. Dopamine dysfunction is associated with symptoms of schizophrenia. However, whether the dopamine system is involved in MMN impairment remains controversial. In this study, we investigated the effects of the dopamine D2-like receptor agonist quinpirole on mismatch responses to sound frequency changes in an animal model. Methods Event-related potentials were recorded from electrocorticogram electrodes placed on the auditory and frontal cortices of freely moving rats using a frequency oddball paradigm consisting of ascending and equiprobable (ie, many standards) control sequences before and after the subcutaneous administration of quinpirole. To detect mismatch responses, difference waveforms were obtained by subtracting nondeviant control waveforms from deviant waveforms. Results Here, we show the significant effects of quinpirole on frontal mismatch responses to sound frequency deviations in rats. Quinpirole delayed the frontal N18 and P30 mismatch responses and reduced the frontal N55 MMN-like response, which resulted from the reduction in the N55 amplitude to deviant stimuli. Importantly, the magnitude of the N55 amplitude was negatively correlated with the time of the P30 latency in the difference waveforms. In contrast, quinpirole administration did not clearly affect the temporal mismatch responses recorded from the auditory cortex. Conclusion These results suggest that the disruption of dopamine D2-like receptor signaling by quinpirole reduces frontal MMN to sound frequency deviations and that delays in early mismatch responses are involved in this MMN impairment.
机译:目的降低的错配消极性(MMN)反应是精神分裂症的有希望的电生理学内型,反映了神经认知障碍。多巴胺功能障碍与精神分裂症的症状有关。然而,多巴胺系统是否涉及MMN损伤仍然存在争议。在这项研究中,我们研究了多巴胺D2的受体激动剂quinpirole对动物模型中声频变化的错配响应的影响。方法使用频率奇数球域的频率奇数球域(即在皮下施用的喹啉之前和之后的频率奇数球域,从放置在自由移动大鼠的听觉和额叶的电压图电极中记录了事件相关电位。为了检测不匹配响应,通过从偏差波形中减去非凡的控制波形来获得差异波形。结果在此,我们展示了quinpirole对对大鼠声音频率偏差的正面错配响应的显着影响。 Quinpirole延迟了正面N18和P30不匹配的响应,并降低了前N55mmn样响应,从而减少了N55幅度与偏差刺激。重要的是,N55幅度的幅度与差值波形中的P30延迟的时间呈负相关。相比之下,喹罗lole管理没有明确影响从听觉皮质记录的时间不匹配响应。结论这些结果表明,Quinpirole的多巴胺D2样受体信号传导的破坏减少了前部MMN到声频偏差,并且早期不匹配响应的延迟涉及该MMN损伤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号